REAL

EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer

Cserepes, Mihály and Nelhűbel, Györgyi A. and Meilinger-Dobra, Mónika and Herczeg, Adrienn and Türk, Dóra and Hegedűs, Zita and Svajda, Laura and Rásó, Erzsébet and Ladányi, Andrea and Csikó, Kristóf György and Kenessey, István and Szöőr, Árpád and Vereb, György and Remenár, Éva and Tóvári, József (2022) EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer. Cancers, 14 (10). p. 2407. ISSN 2072-6694

[img]
Preview
Text
cancers-14-02407-v2.pdf

Download (2MB) | Preview
Item Type: Article
Subjects: R Medicine / orvostudomány > R1 Medicine (General) / orvostudomány általában > R850-854 Experimental medicine / kisérleti orvostudomány
Depositing User: Dr Árpád Szöőr
Date Deposited: 28 Sep 2022 08:37
Last Modified: 28 Sep 2022 08:37
URI: http://real.mtak.hu/id/eprint/150220

Actions (login required)

Edit Item Edit Item